Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 6151–6200 of 75459
On April 18, 2025, Mr. Jing Jin, the chief financial officer of Greenland Technologies Holding Corporation, a business company formed in the British Virgin Islands (the “Company”), resigned as the chief financial officer of the Company, effective April 18, 2025.
On April 17, 2025, John (Fei) Han was appointed as the Chief Financial Officer of the Defi Development Corp., formerly known as Janover Inc. (the “ Company ”).
In connection with Mr. Han’s appointment as the Chief Financial Officer of the Company, Mr. Rosenbloom stepped down as the Chief Financial Officer of the Company, effective immediately.
He is succeeded by Paul Fipps, who was appointed President of Global Customer Operations.
On April 21, 2025, Paul Smith notified the Company of his decision to resign from his position as the Company’s President, Global Customer and Field Operations, effective April 23, 2025.
On April 18, 2025, Michael D. Belsky notified the Board of Directors of Professional Diversity Network, Inc. (the “Company”) of his decision to resign from the Company’s Board of Directors effective immediately.
appointed Mr. Long Yi to fill the vacancy created by Mr. Chris Renn’s resignation
On April 19, 2025, Chris Renn notified the Company of his decision to resign from the Company’s Board of Directors effective immediately.
appointed Ms. Eloisa Sultan to fill the vacancy created by Mr. Michael D. Belsky’s resignation
On April 18, 2025, the Board of Directors of MediXall Group, Inc. (the "Company") appointed the following as members of the Board of Directors: Susan Poniatowski, Garth Walker, Gene Shvedov.
On April 18, 2025, the Board of Directors of MediXall Group, Inc. (the "Company") appointed the following as members of the Board of Directors: Susan Poniatowski, Garth Walker, Gene Shvedov.
On April 18, 2025, the Board of Directors of MediXall Group, Inc. (the "Company") appointed the following as members of the Board of Directors: Susan Poniatowski, Garth Walker, Gene Shvedov.
In addition, on April 18, 2025, the Board of Directors accepted the resignations of Travis Jackson and John Marino
In addition, on April 18, 2025, the Board of Directors accepted the resignations of Travis Jackson and John Marino
The reappointment follows Mike Nelson’s departure from the role of Chief Executive Officer
On April 18, 2025 the Board of Directors of Basanite, Inc. (the “Company”) approved the reappointment of Ronald LoRicco, Sr. as the Company’s Acting Interim Chief Executive Officer, effective immediately.
On April 17, 2025, Adagio Medical Holdings, Inc. (the “Company”) appointed Daniel George as the Company’s Interim Chief Financial Officer and designated Mr. George as its principal financial officer and principal accounting officer.
On April 21, 2025, Eyal Rubin, Sr. Vice President and Chief Financial Officer of Protalix BioTherapeutics, Inc., a Delaware corporation (the “Company”), provided the Company and the Company’s Board of Directors with six months’ notice of his resignation from his position with the Company and its subsidiary, in order to pursue other opportunities.
The Bank has appointed Peter Downs (60), the Company’s and Bank’s Chief Lending Officer, as President of the Bank, effective April 22, 2025;
On April 21, 2025, Nicolas Young provided notice of his resignation as President and Chief Operating Officer of the Company’s subsidiary Newtek Bank, N.A. (the “Bank”), effective May 16, 2025.
Also, effective April 22, 2025, the Company has named Frank DeMaria (36) as Chief Financial Officer of the Company.
the Board, upon recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Dr. Poma to serve as a Class I director of the Company, also effective April 22, 2025
Allan Camaisa notified the board of directors (“Board”) of Calidi Biotherapeutics, Inc. (the “Company”) of his resignation as the Company’s Chief Executive Officer (“CEO”) and as Chairman of the Board
the Board, by a unanimous vote, appointed Eric Poma, Ph.D. to serve as CEO of the Company, effective April 22, 2025.
Allan Camaisa notified the board of directors (“Board”) of Calidi Biotherapeutics, Inc. (the “Company”) of his resignation as the Company’s Chief Executive Officer (“CEO”) and as Chairman of the Board
On April 22, 2025, Jake Kurtis notified the Company of his immediate resignation as a director of the Company to pursue other interests.
replacing Dan Mapes who has retired from such position
James Hendrickson, the Chief Operating Officer of the Company, has also assumed the role of President of the Company
On April 21, 2025, the Board appointed Mr. Xiaohua Lu as the Chief Executive Officer of the Company.
On April 21, 2025, the Board of Directors (the “Board”) of Nova LifeStyle, Inc. (the “Company”) received a resignation letter from Ms. Thanh H. Lam to resign from her positions as the Chief Executive Officer (“CEO”) and President of the Company, effective immediately.
On April 17, 2025, Dominic L. Hunter, age 62, commenced employment as Chief Financial Officer of the Company.
Driven Brands Holdings Inc. (the “Company”) has appointed Rebecca Fondell to serve as the Company’s Senior Vice President and Chief Accounting Officer (“CAO”) effective as of May 9, 2025.
On April 20, 2025, George Kelly Martin informed the Board of Directors (the “Board”) of TriSalus Life Sciences, Inc. (the “Company”) of his decision to resign from his position as a member of the Board, the Audit Committee of the Board and the Compensation Committee of the Board, effective immediately.
On April 22, 2025, the board of directors of the Company (the "Board") also elected Mr. Stepien to serve as a Class I director, effective May 1, 2025.
On April 23, 2025, Amprius Technologies, Inc. (the "Company") announced that Mr. Tom Stepien, had been appointed President of the Company.
On April 22, 2025, the Company announced that Sara Velazquez Ponessa has been named Executive Vice President, General Counsel and Corporate Secretary succeeding Mr. Reilly, effective June 1, 2025.
On April 22, 2025, FMC Corporation (“FMC” or the “Company”) announced that Mr. Michael F. Reilly will retire from his positions as Executive Vice President, General Counsel, Chief Compliance Officer and Secretary of the Company effective June 1, 2025, and retire fully from the Company effective July 1, 2025.
In connection with this transition, the Company appointed Eric A. Mendelson and Victor H. Mendelson to serve as Co-Chief Executive Officers (co-principal executive officers), also effective May 1, 2025.
In connection with this transition, the Company appointed Eric A. Mendelson and Victor H. Mendelson to serve as Co-Chief Executive Officers (co-principal executive officers), also effective May 1, 2025.
Effective May 1, 2025, Laurans A. Mendelson, the Company’s Chairman and Chief Executive Officer (principal executive officer), will assume the role of Executive Chairman of the Board.
The Board also appointed Deborah Grant, an existing member of the Board and the Chair of the Company’s Compensation and Human Capital Committee, to serve as the Company’s Board Chair, also effective immediately prior to the Annual Meeting.
On April 17, 2025, SoundThinking, Inc. (the “Company”) announced that Burton Goldfield had been appointed to the Board of Directors (the “Board”) of the Company as a Class II director.
Election of New Director On April 16, 2025, the Board of Directors (the “Board”) of the Company elected Ms. Danielle Sheer to serve as a member of the Board, as a Class II director, and appointed her to serve on the Nomination and Governance Committee, both effective as of May 13, 2025.
Ms. Sheer initially will serve the remainder of the term of co-founder and long-term director Mr. Deepak Raghavan, who is retiring as of May 13, 2025.
On April 21, 2025, the Board of Directors (the “Board”) of Sight Sciences, Inc. (the “Company”), upon the recommendation of its Nominating and Corporate Governance Committee, appointed Gerhard F. Burbach to the Board.
Philip E. Norment was not nominated for re-election to the Board of Directors of Ryerson Holding Corporation (“Ryerson” or the “Company”), and effective as of April 17, 2025, he ceased to serve as a director of the Company.
Wei Hopeman has informed Booking Holdings Inc. (the "Company") that she has decided to retire from the Company's Board of Directors (the "Board"), effective at the Company's Annual Meeting in June 2025 (the "Annual Meeting"), and therefore is not standing for re-election at the Annual Meeting.
On April 22, 2025, Sam Altman notified the board of directors (the “Board”) of Oklo Inc. (the “Company”) that he intended to resign as Chair and as a Class II director of the Board, including as a member of the Board’s Nominating and Corporate Governance Committee, effective April 22, 2025.
Peter Bruce who has ceased to serve as Chief Operating Officer of the Fund, effective as of April 16, 2025.
appointed Zachary Feingold as Chief Operating Officer of the Fund, effective immediately
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.